192 related articles for article (PubMed ID: 32938950)
41. Exploring the VISTA of microglia: immune checkpoints in CNS inflammation.
Borggrewe M; Kooistra SM; Noelle RJ; Eggen BJL; Laman JD
J Mol Med (Berl); 2020 Oct; 98(10):1415-1430. PubMed ID: 32856125
[TBL] [Abstract][Full Text] [Related]
42. VISTA: a novel immunotherapy target for normalizing innate and adaptive immunity.
ElTanbouly MA; Croteau W; Noelle RJ; Lines JL
Semin Immunol; 2019 Apr; 42():101308. PubMed ID: 31604531
[TBL] [Abstract][Full Text] [Related]
43. Novel Benzimidazoles as Potent Small-Molecule Inhibitors and Degraders of V-Domain Ig Suppressor of T-Cell Activation (VISTA).
Wang T; Wang K; Zhang Y; Zhang K; Cai S; Jiang S; Xiao Y; Zhang X
J Med Chem; 2023 Sep; 66(17):11881-11892. PubMed ID: 37594853
[TBL] [Abstract][Full Text] [Related]
44. Agonistic nanobodies and antibodies to human VISTA.
Ma YV; Sparkes A; Romão E; Saha S; Gariépy J
MAbs; 2021; 13(1):2003281. PubMed ID: 34818120
[TBL] [Abstract][Full Text] [Related]
45. Expression and function of VISTA on myeloid cells.
Li S; Wang G; Ren Y; Liu X; Wang Y; Li J; Liu H; Yang J; Xing J; Zhang Y; He C; Xu S; Hou X; Li N
Biochem Pharmacol; 2024 Apr; 222():116100. PubMed ID: 38428824
[TBL] [Abstract][Full Text] [Related]
46. VISTA Is Crucial for Corneal Allograft Survival and Maintenance of Immune Privilege.
Kunishige T; Taniguchi H; Ohno T; Azuma M; Hori J
Invest Ophthalmol Vis Sci; 2019 Dec; 60(15):4958-4965. PubMed ID: 31790558
[TBL] [Abstract][Full Text] [Related]
47. The polymorphism rs975484 in the protein arginine methyltransferase 1 gene modulates expression of immune checkpoint genes in hepatocellular carcinoma.
Schonfeld M; Zhao J; Komatz A; Weinman SA; Tikhanovich I
J Biol Chem; 2020 May; 295(20):7126-7137. PubMed ID: 32245889
[TBL] [Abstract][Full Text] [Related]
48. The prognostic significance of VISTA and CD33-positive myeloid cells in cutaneous melanoma and their relationship with PD-1 expression.
Choi JW; Kim YJ; Yun KA; Won CH; Lee MW; Choi JH; Chang SE; Lee WJ
Sci Rep; 2020 Sep; 10(1):14372. PubMed ID: 32873829
[TBL] [Abstract][Full Text] [Related]
49. Development of unique cytotoxic chimeric antigen receptors based on human scFv targeting B7H6.
Hua CK; Gacerez AT; Sentman CL; Ackerman ME
Protein Eng Des Sel; 2017 Oct; 30(10):713-721. PubMed ID: 29040754
[TBL] [Abstract][Full Text] [Related]
50. Potential Therapeutic Targets of B7 Family in Colorectal Cancer.
Wang C; Feng H; Cheng X; Liu K; Cai D; Zhao R
Front Immunol; 2020; 11():681. PubMed ID: 32477326
[TBL] [Abstract][Full Text] [Related]
51. Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights.
Noelle RJ; Lines JL; Lewis LD; Martell RE; Guillaudeux T; Lee SW; Mahoney KM; Vesely MD; Boyd-Kirkup J; Nambiar DK; Scott AM
Front Oncol; 2023; 13():1225081. PubMed ID: 37795437
[TBL] [Abstract][Full Text] [Related]
52. Decreased Expression of Negative Immune Checkpoint VISTA by CD4+ T Cells Facilitates T Helper 1, T Helper 17, and T Follicular Helper Lineage Differentiation in GCA.
Hid Cadena R; Reitsema RD; Huitema MG; van Sleen Y; van der Geest KSM; Heeringa P; Boots AMH; Abdulahad WH; Brouwer E
Front Immunol; 2019; 10():1638. PubMed ID: 31379838
[TBL] [Abstract][Full Text] [Related]
53. VISTA checkpoint inhibition by pH-selective antibody SNS-101 with optimized safety and pharmacokinetic profiles enhances PD-1 response.
Thisted T; Smith FD; Mukherjee A; Kleschenko Y; Feng F; Jiang ZG; Eitas T; Malhotra K; Biesova Z; Onumajuru A; Finley F; Cifuentes A; Zhang G; Martin GH; Takeuchi Y; Thiam K; Schreiber RD; van der Horst EH
Nat Commun; 2024 Apr; 15(1):2917. PubMed ID: 38575562
[TBL] [Abstract][Full Text] [Related]
54. CD71+VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-β.
Shahbaz S; Bozorgmehr N; Koleva P; Namdar A; Jovel J; Fava RA; Elahi S
PLoS Biol; 2018 Dec; 16(12):e2006649. PubMed ID: 30550561
[TBL] [Abstract][Full Text] [Related]
55. Kidney VISTA prevents IFN-γ/IL-9 axis-mediated tubulointerstitial fibrosis after acute glomerular injury.
Kim MG; Yun D; Kang CL; Hong M; Hwang J; Moon KC; Jeong CW; Kwak C; Kim DK; Oh KH; Joo KW; Kim YS; Lee DS; Han SS
J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34752423
[TBL] [Abstract][Full Text] [Related]
56. Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activity.
Loo D; Alderson RF; Chen FZ; Huang L; Zhang W; Gorlatov S; Burke S; Ciccarone V; Li H; Yang Y; Son T; Chen Y; Easton AN; Li JC; Rillema JR; Licea M; Fieger C; Liang TW; Mather JP; Koenig S; Stewart SJ; Johnson S; Bonvini E; Moore PA
Clin Cancer Res; 2012 Jul; 18(14):3834-45. PubMed ID: 22615450
[TBL] [Abstract][Full Text] [Related]
57. Novel cross-reactive anti-idiotype antibodies with properties close to the human intravenous immunoglobulin (IVIg).
Macias A; Arce S; Leon J; Mustelier G; Bombino G; Domarco A; Perez R; Lage A
Hybridoma; 1999 Jun; 18(3):263-72. PubMed ID: 10475241
[TBL] [Abstract][Full Text] [Related]
58. Blocking the VISTA pathway enhances disease progression in (NZB × NZW) F1 female mice.
Sergent PA; Plummer SF; Pettus J; Mabaera R; DeLong JK; Pechenick DA; Burns CM; Noelle RJ; Ceeraz S
Lupus; 2018 Feb; 27(2):210-216. PubMed ID: 28659048
[TBL] [Abstract][Full Text] [Related]
59. VISTA Re-programs Macrophage Biology Through the Combined Regulation of Tolerance and Anti-inflammatory Pathways.
ElTanbouly MA; Schaafsma E; Smits NC; Shah P; Cheng C; Burns C; Blazar BR; Noelle RJ; Mabaera R
Front Immunol; 2020; 11():580187. PubMed ID: 33178206
[TBL] [Abstract][Full Text] [Related]
60. VISTA is an activating receptor in human monocytes.
Rogers BM; Smith L; Dezso Z; Shi X; DiGiammarino E; Nguyen D; Sethuraman S; Zheng P; Choi D; Zhang D; Nguyen A; McGuire K; Liu W; Chung N; Chao DT; Ye S; Starbeck-Miller GR
J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34106206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
